Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesReceivables - AccuredReceivables - NetRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Indemnity (GBLI) Cash & Equivalents (2016 - 2025)

Global Indemnity has reported Cash & Equivalents over the past 16 years, most recently at $75.4 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 142.95% year-over-year to $75.4 million; the TTM value through Sep 2025 reached $75.4 million, up 142.95%, while the annual FY2024 figure was $17.0 million, 55.28% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $75.4 million at Global Indemnity, up from $67.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $157.9 million in Q1 2022 and troughed at $17.0 million in Q4 2024.
  • A 5-year average of $53.4 million and a median of $46.5 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 232.66% in 2022 and later tumbled 77.37% in 2023.
  • Year by year, Cash & Equivalents stood at $78.3 million in 2021, then tumbled by 50.37% to $38.8 million in 2022, then dropped by 2.08% to $38.0 million in 2023, then tumbled by 55.28% to $17.0 million in 2024, then skyrocketed by 343.06% to $75.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for GBLI at $75.4 million in Q3 2025, $67.3 million in Q2 2025, and $81.1 million in Q1 2025.